e7aa3952_ed_Radionuclide_Therapy___HTML_euticals_for_targeted_therapy__Targeting_mechanism
[Radiopharmaceutical] Y-90 Octreotide [Indications] Neuroendocrine tumors [Targeting mechanism] 
Somatostatin receptor binding
Cancers | Free Full-Text | Targeted Radionuclide Therapy | HTML